Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26238524 | 0.83 | P2RX7 (0.36) | CHRNB4CHRNA3CHRNB2CHRNA4SIGMAR1 | |
| SCHEMBL15222074 | 0.78 | SMN1; SMN2 (0.41) | CHRNB4CHRNA3CHRNB2CHRNA4SIGMAR1 | |
| SCHEMBL18707101 | 0.78 | TP53 (0.40) | TP53 | |
| SCHEMBL17957884 | 0.75 | AGTR1 (0.43) | — | |
| SCHEMBL17957882 | 0.75 | AGTR1 (0.43) | — | |
| SCHEMBL13155623 | 0.74 | OPRM1 (0.49) | SIGMAR1 | |
| SCHEMBL13452979 | 0.74 | OPRM1 (0.49) | SIGMAR1 | |
| SCHEMBL14135549 | 0.74 | OPRM1 (0.49) | SIGMAR1 | |
| SCHEMBL13091467 | 0.74 | SIGMAR1 (0.36) | DRD2DRD1DRD4SIGMAR1TP53 | |
| SCHEMBL13490300 | 0.73 | L3MBTL1 (0.41) | CHRNB4CHRNA3CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017060854-A1 | BIARYL PYRAZOLES AS NRF2 REGULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-04-13 | — | — | WO | disclosed |